Dr. Noelle Cutter is an associate professor and director of the First Year Experience at Molloy College. By training, she is a scientist in the field of molecular biology where she has dedicated her career to studying alternative treatment options for pediatric patients diagnosed with a rare and aggressive form of brain cancer known as medulloblastoma. Dr. Cutter is most interested in the role that methylation plays in gene regulation allowing tumors to grow and divide. By doing so, she hopes to be able to better diagnose patients so they can be treated more efficiently. During the COVID19 pandemic, Dr. Cutter worked in an antibody testing lab where she worked on designing synthetic peptides to test for the presence of SARS-Cov2 antibody in patient serum. Her work on the ELISA testing plate was implemented in numerous labs across New York and Colorado. Her collaboration in this work was one of the first successful testing platforms for the novel 2019 coronavirus. She has since continued her efforts, working alongside science advocates on Long Island to help in the distribution of the COVID-19 vaccine. The goal is to make sure the distribution is fair and equitable to the general public.
